BRIEF published on 01/15/2026 at 11:50, 8 months 17 days ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/15/2026 at 11:45, 8 months 17 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses ownership of 0.04% of Avadel Pharmaceuticals plc shares as of 14-Jan-2026, as per Form 8.3 filing with the Irish Takeover Panel Form 8.3 Irish Takeover Panel Ownership Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/14/2026 at 14:35, 8 months 18 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Disclosure Irish Takeover Panel Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/14/2026 at 14:30, 8 months 18 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed 1.55% stake in Avadel Pharmaceuticals plc on 13th January 2026 Disclosure Irish Takeover Panel Stake Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/06/2026 at 12:50, 8 months 26 days ago Zürcher Kantonalbank Discloses Stake in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/06/2026 at 12:45, 8 months 26 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose a 0.04% interest in Avadel Pharmaceuticals plc. Details of open stock-settled derivatives positions provided Disclosure Irish Takeover Panel Stock-settled Derivatives Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 20:35, 8 months 27 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Holding Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 20:30, 8 months 27 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed a 1.02% interest in Avadel Pharmaceuticals plc shares on 2nd January 2026 Shares Disclosure Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 17:05, 8 months 27 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 17:00, 8 months 27 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.02% position in Avadel Pharmaceuticals plc as of 31st December 2025 following dealing activities Position Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc 1.02% Dealing Activities
Published on 10/02/2026 at 00:30, 6 hours 57 minutes ago Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 8 hours 22 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 9 hours 27 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/02/2026 at 07:00, 26 minutes ago Julius Baer announces CHF 600 million share buy-back and revised capital distribution policy
Published on 10/02/2026 at 06:33, 54 minutes ago MHM CORPORATE — 2026 Half-Year Results and Publication of the Half-Year Financial Report
Published on 10/02/2026 at 06:05, 1 hour 21 minutes ago 19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD
Published on 10/02/2026 at 04:05, 3 hours 21 minutes ago Angel Aligner Upgrades Torque Ridges to "Pressure Points" in Europe
Published on 10/02/2026 at 00:01, 7 hours 26 minutes ago PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 19:00, 12 hours 27 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 12 hours 46 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 13 hours 22 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 10/01/2026 at 18:00, 13 hours 26 minutes ago Saint-Gobain completes the acquisition of Xypex (North America), a leader in high value-added waterproofing solutions
Published on 10/01/2026 at 17:55, 13 hours 31 minutes ago Disclosure of transactions in own shares from September 28 to September 30, 2026
